Vascular endothelial growth factor (VEGF) plays a key role in the pathophysiology of many retinal disorders including, but not limited by, neovascular age-related macular degeneration (nAMD), diabetic retinopathy, retinal vein occlusions (RVO) and some entities of the pachychoroid spectrum. This evidence concerns the gene VEGFA and retinal vein occlusion.